Beck Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.7M Buy
6,202
+120
+2% +$122K 1.31% 29
2025
Q4
$6.54M Buy
6,082
+64
+1% +$61.2K 1.56% 18
2025
Q3
$4.59M Sell
6,018
-26
-0.4% -$19.3K 1.06% 38
2025
Q2
$4.71M Sell
6,044
-104
-2% -$80.8K 1.18% 32
2025
Q1
$5.08M Sell
6,148
-524
-8% -$436K 1.49% 21
2024
Q4
$5.15M Sell
6,672
-423
-6% -$350K 1.37% 25
2024
Q3
$6.29M Sell
7,095
-1,825
-20% -$1.64M 1.68% 16
2024
Q2
$8.08M Buy
8,920
+96
+1% +$76.8K 2.22% 9
2024
Q1
$6.86M Buy
8,824
+163
+2% +$116K 1.97% 10
2023
Q4
$5.05M Sell
8,661
-4,096
-32% -$2.39M 1.73% 16
2023
Q3
$6.85M Sell
12,757
-352
-3% -$181K 2.64% 3
2023
Q2
$6.15M Buy
13,109
+1,785
+16% +$749K 2.42% 3
2023
Q1
$3.89M Buy
11,324
+193
+2% +$65.1K 1.65% 12
2022
Q4
$4.07M Buy
11,131
+3,749
+51% +$1.33M 1.71% 9
2022
Q3
$2.39M Buy
+7,382
New +$2.34M 1.02% 35

Other funds holding LLY

Beck Capital Management's LLY Position: Q1 2026 in Review

Beck Capital Management increased its Eli Lilly (LLY) stake by 2% in Q1 2026, buying an estimated $122K and bringing the position to 6,202 shares worth $5.7M. The position accounts for 1.31% of the portfolio, ranked #29.

Beck Capital Management first reported a position in LLY in Q3 2022 and has held it in 15 quarters since. The position peaked at $8.08M in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Beck Capital Management held 6,202 shares of Eli Lilly worth $5.7M as of Q1 2026.
  • Beck Capital Management bought 120 Eli Lilly shares in Q1 2026, an estimated $122K.
  • Eli Lilly made up 1.31% of Beck Capital Management's portfolio in Q1 2026, its #29 holding.
  • Beck Capital Management first reported a position in Eli Lilly in Q3 2022 and has held it in 15 quarters since.
  • Beck Capital Management's Eli Lilly position peaked at $8.08M in Q2 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Beck Capital Management's 13F filing for Q1 2026, filed 15 May 2026.